期刊
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
卷 59, 期 -, 页码 S256-S261出版社
WILEY
DOI: 10.1111/j.1532-5415.2011.03702.x
关键词
delirium; biomarkers; serum
资金
- National Institute on Aging [R01AG034205-01A1]
- National Institute on Mental Health [R24MH080827]
To improve delirium recognition and care, numerous serum biomarkers have been investigated as potential tools for risk stratification, diagnosis, monitoring, and prognostication of delirium. The literature was reviewed, and no evidence was found to support the clinical use of any delirium biomarker, although certain biomarkers such as S-100 beta and insulin-like growth factor-1 and inflammatory markers have shown some promising results that need to be evaluated in future studies with appropriate sample size, prospective designs, and in a more-generalizable population. J Am Geriatr Soc 59:S256-S261, 2011.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据